Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017 (2017), Article ID 2453254, 10 pages
https://doi.org/10.1155/2017/2453254
Research Article

Cost-Effectiveness Analysis of Helicobacter pylori Diagnostic Methods in Patients with Atrophic Gastritis

1Department of Internal Medicine, St. Luke’s International Hospital, Chuo-Ku, Japan
2Center for Clinical Epidemiology, St. Luke’s International University, Chuo-Ku, Japan
3Ohta Nishinouchi Hospital, Koriyama, Japan

Correspondence should be addressed to Fumio Omata; moc.duolci@fatamo

Received 10 November 2016; Revised 6 January 2017; Accepted 11 January 2017; Published 23 February 2017

Academic Editor: Tatsuya Toyokawa

Copyright © 2017 Fumio Omata et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Hirayama, T. Kawai, J. Otaki, K. Kawakami, and Y. Harada, “Prevalence of Helicobacter pylori infection with healthy subjects in Japan,” Journal of Gastroenterology and Hepatology, vol. 29, Supplement 4, pp. 16–19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Kamada, K. Haruma, M. Ito et al., “Time trends in Helicobacter pylori infection and atrophic gastritis over 40 years in Japan,” Helicobacter, vol. 20, no. 3, pp. 192–198, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. V. De Francesco, F. Giorgio, C. Hassan et al., “Worldwide H. pylori antibiotic resistance: a systematic review,” Journal of Gastrointestinal and Liver Diseases, vol. 19, no. 4, pp. 409–414, 2010. View at Google Scholar
  4. S. Shiota, R. Reddy, A. Alsarraj, H. B. El-Serag, and D. Y. Graham, “Antibiotic resistance of Helicobacter pylori among male United States veterans,” Clinical Gastroenterology and Hepatology, vol. 13, no. 9, pp. 1616–1624, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. T. T. Schubert, S. D. Bologna, Y. Nensey, A. B. Schubert, E. J. Mascha, and C. K. Ma, “Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age,” The American Journal of Medicine, vol. 94, no. 4, pp. 413–418, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Fukao, S. Komatsu, Y. Tsubono et al., “Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study,” Cancer Causes & Control: CCC, vol. 4, no. 4, pp. 307–312, 1993. View at Google Scholar
  7. D. Forman, D. G. Newell, F. Fullerton et al., “Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation,” BMJ, vol. 302, no. 6788, pp. 1302–1305, 1991. View at Publisher · View at Google Scholar
  8. Y. S. Kim, J. S. Kim, H. C. Jung et al., “Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation,” Journal of Gastroenterology, vol. 37, no. 1, pp. 17–22, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Suzuki, M. Matsushima, A. Masui et al., “Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial,” The American Journal of Gastroenterology, vol. 100, no. 6, pp. 1265–1270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Watabe, T. Mitsushima, M. H. Derakhshan et al., “Study of association between atrophic gastritis and body mass index: a cross-sectional study in 10,197 Japanese subjects,” Digestive Diseases and Sciences, vol. 54, no. 5, pp. 988–995, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Eun Bae, J. Hoon Lee, Y. Soo Park et al., “Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference,” Scandinavian Journal of Gastroenterology, vol. 51, no. 2, pp. 137–144, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Murakami, Y. Sakurai, M. Shiino, N. Funao, A. Nishimura, and M. Asaka, “Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study,” Gut, vol. 65, no. 9, pp. 1439–1446, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Asaka, T. Sugiyama, M. Kato et al., “A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients,” Helicobacter, vol. 6, no. 3, pp. 254–261, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Ducons, S. Santolaria, R. Guirao, M. Ferrero, M. Montoro, and F. Gomollón, “Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer,” Alimentary Pharmacology & Therapeutics, vol. 13, no. 6, pp. 775–780, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. C. S. Park, S. M. Lee, C. H. Park et al., “Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance,” The American Journal of Gastroenterology, vol. 109, no. 10, pp. 1595–1602, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Matsuhisa, T. Kawai, T. Masaoka et al., “Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori infection in the Japanese population: a multicenter study in the Tokyo metropolitan area,” Helicobacter, vol. 11, no. 3, pp. 152–158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Murakami, T. Furuta, T. Ando et al., “Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan,” Journal of Gastroenterology, vol. 48, no. 10, pp. 1128–1135, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. Igakutsushinsha, Quick Manual for Reimbursement, April 2015 Version: Igakutsushinsha, 2015.
  19. Igakutsushinsha, Quick Manual for DPC Score, April 2015 Version: Igakutsushinsha, 2015.
  20. A. C. Ford, D. Forman, R. H. Hunt, Y. Yuan, and P. Moayyedi, “Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials,” BMJ, vol. 348, article g3174, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Yakugyokenkyukai, Insured Drug Dictionary, Jihosha, Plus, 2015.
  22. F. Omata, S. Ohde, G. A. Deshpande et al., “Diagnostic performance of three endoscopic tests for Helicobacter pylori infection: systematic review and meta-analysis,” The American Journal of Gastroenterology, vol. 110, 2015. View at Google Scholar
  23. M. Ferwana, I. Abdulmajeed, A. Alhajiahmed et al., “Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis,” World Journal of Gastroenterology, vol. 21, no. 4, pp. 1305–1314, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. C. T. Loy, L. M. Irwig, P. H. Katelaris, and N. J. Talley, “Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis,” The American Journal of Gastroenterology, vol. 91, no. 6, pp. 1138–1144, 1996. View at Google Scholar
  25. J. P. Gisbert, F. de la Morena, and V. Abraira, “Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis,” The American Journal of Gastroenterology, vol. 101, no. 8, pp. 1921–1930, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Yamamoto, N. Uemura, S. Okamoto, S. Yamaguchi, H. Mashiba, and T. Tachikawa, “A new rapid test for detecting anti-Helicobacter pylori antibody excreted into urine,” Helicobacter, vol. 5, no. 3, pp. 160–164, 2000. View at Publisher · View at Google Scholar
  27. D. Y. Graham and S. Reddy, “Rapid detection of anti-Helicobacter pylori IgG in urine using immunochromatography,” Alimentary Pharmacology & Therapeutics, vol. 15, no. 5, pp. 699–702, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Fujisawa, T. Kaneko, T. Kumagai et al., “Evaluation of urinary rapid test for Helicobacter pylori in general practice,” Journal of Clinical Laboratory Analysis, vol. 15, no. 3, pp. 154–159, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. W. M. Wong, B. C. Wong, H. H. Xia et al., “An evaluation of a rapid urine test for the diagnosis of Helicobacter pylori infection in the Chinese population,” Alimentary Pharmacology & Therapeutics, vol. 16, no. 4, pp. 813–817, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Adachi, A. Kawamura, M. Ono et al., “Comparative evaluation of urine-based and other minimally invasive methods for the diagnosis of Helicobacter pylori infection,” Journal of Gastroenterology, vol. 37, no. 9, pp. 703–708, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Leodolter, D. Vaira, F. Bazzoli et al., “European multicentre validation trial of two new non-invasive tests for the detection of Helicobacter pylori antibodies: urine-based ELISA and rapid urine test,” Alimentary Pharmacology & Therapeutics, vol. 18, no. 9, pp. 927–931, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Y. Lu, F. C. Kuo, S. W. Wang et al., “The clinical applications and accuracy of 2 rapid near-patient tests in detecting Helicobacter pylori infection,” Diagnostic Microbiology and Infectious Disease, vol. 56, no. 3, pp. 241–246, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. A. R. Opekun, P. Luu, A. B. Gotschall et al., “Point-of-care Helicobacter pylori urine antibody detection in a multi-ethnic adult population in the United States,” Translational Research, vol. 148, no. 1, pp. 13–18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Demiray Gurbuz, C. Gonen, N. Bekmen et al., “The diagnostic accuracy of urine IgG antibody tests for the detection of Helicobacter pylori infection in Turkish dyspeptic patients,” The Turkish Journal of Gastroenterology, vol. 23, no. 6, pp. 753–758, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. D. T. Quach, T. Hiyama, F. Shimamoto et al., “Value of a new stick-type rapid urine test for the diagnosis of Helicobacter pylori infection in the Vietnamese population,” World Journal of Gastroenterology, vol. 20, no. 17, pp. 5087–5091, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. A. F. Syam, M. Miftahussurur, W. B. Uwan, D. Simanjuntak, T. Uchida, and Y. Yamaoka, “Validation of urine test for detection of Helicobacter pylori infection in Indonesian population,” BioMed Research International, vol. 2015, Article ID 152823, 6 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Horiki, F. Omata, M. Uemura et al., “Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan,” Helicobacter, vol. 14, no. 5, pp. 86–90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Elwyn, M. Taubert, S. Davies, G. Brown, M. Allison, and C. Phillips, “Which test is best for Helicobacter pylori? A cost-effectiveness model using decision analysis,” The British Journal of General Practice, vol. 57, no. 538, pp. 401–403, 2007. View at Google Scholar
  39. Research Center of Cancer Prevention and Screening NCI. Gastric Cancer Screening Guideline Based on Effectiveness, 2014 Version, National cancer institute, USA, 2014.
  40. D. E. Taylor, “Pathophysiology of antibiotic resistance: clarithromycin,” Canadian Journal of Gastroenterology, vol. 14, no. 10, pp. 891–894, 2000. View at Publisher · View at Google Scholar
  41. T. Okamura, T. Suga, T. Nagaya et al., “Antimicrobial resistance and characteristics of eradication therapy of Helicobacter pylori in Japan: a multi-generational comparison,” Helicobacter, vol. 19, no. 3, pp. 214–220, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Kawabata, Y. Habu, H. Tomioka et al., “Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin,” Alimentary Pharmacology & Therapeutics, vol. 17, no. 2, pp. 259–264, 2003. View at Publisher · View at Google Scholar · View at Scopus